Overview
- The U.S. Supreme Court on June 25 ruled for Bayer/Monsanto, overturning a $1.25 million jury verdict and endorsing a federal-law argument that can bar state failure-to-warn claims over glyphosate-based weedkillers.
- The Trump administration’s Department of Justice filed or joined briefs supporting Bayer’s position in the case, and the court’s opinion relied on the interplay between federal pesticide law and state tort claims.
- President Trump earlier this year signed an executive order to prioritize U.S. production of glyphosate, a move the White House framed as a supply-chain and national-security action that MAHA critics view as favoring industry.
- Leaders and activists in the Make America Healthy Again movement say they feel betrayed by the administration and the court, with prominent MAHA figures warning the decision could depress or shift their voters’ support in the 2026 midterms.
- Coverage differs in tone but not in facts: some outlets foreground MAHA’s political revolt and potential voter consequences, others emphasize RFK Jr.’s muted response and the broader debate over regulatory capture and corporate accountability.